2018
DOI: 10.3389/fphar.2018.00478
|View full text |Cite
|
Sign up to set email alerts
|

MicroRNA-146a: A Comprehensive Indicator of Inflammation and Oxidative Stress Status Induced in the Brain of Chronic T2DM Rats

Abstract: Objective: It was demonstrated that inflammation and oxidative stress induced by hyperglycemia were closely associated with alteration of miR-146a. Here, we investigated the role of miR-146a in mediating inflammation and oxidative stress in the brain of chronic T2DM rats.Methods: The chronic T2DM (cT2DM) models were induced by intraperitoneal administration of STZ (35 mg/kg) after being fed a high-fat, high-sugar diet for 6 weeks. H&E staining was conducted to observe the morphological impairment of the rat hi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
37
1
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 65 publications
(43 citation statements)
references
References 58 publications
2
37
1
1
Order By: Relevance
“…Increased inflammation and oxidative stress were associated with brain impairment in cT2DM rats, which were negatively correlated with miR-146a expression. The expressions of NF-κB p65 and its specific modulators were elevated in the brain of cT2DM rats, which might be inhibited by miR-146a [87].…”
Section: Nf-κb Pathwaymentioning
confidence: 95%
“…Increased inflammation and oxidative stress were associated with brain impairment in cT2DM rats, which were negatively correlated with miR-146a expression. The expressions of NF-κB p65 and its specific modulators were elevated in the brain of cT2DM rats, which might be inhibited by miR-146a [87].…”
Section: Nf-κb Pathwaymentioning
confidence: 95%
“…Many studies have shown that miR-146a protects against various brain impairments. [17][18][19] It is also involved in the modulation of microglia/macrophages in ischemic stroke. 20 In addition, miR-146a-5p has been reported to be down-regulated in the serum of patients with ICH 21 and to protect against ICH by repressing the TRAF6/NF-κB pathway.…”
Section: Introductionmentioning
confidence: 99%
“…This is attributed mainly to the ability of miR‐146a to regulate the activity of proinflammatory pathways. In this regard, in vivo and in vitro studies have shown that miR‐146a inhibits neuroinflammation by directly targeting IRAK1 and TRAF6 downstream mediators of TLR and cytokine pathways 19–22 . Increased levels of miR‐146a have been detected in brain 23,24 and blood 25,26 samples of patients with epilepsy, and have been associated with chronic neuroinflammation and neuronal loss 23,27–29 .…”
Section: Introductionmentioning
confidence: 99%